Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/8298
Title: Antitumor effect of the chalcone analogue, (E)-1(4-ethoxy-3-methoxyphenyl)-5-methylhex-1-EN-3-one on hela cell line
Authors: Lukovic J.
Mitrovic M.
Zelen I.
Canovic P.
Zaric, Milan
Nikolic I.
Journal: Serbian Journal of Experimental and Clinical Research
Issue Date: 1-Sep-2019
Abstract: © 2019, University of Kragujevac, Faculty of Science. All rights reserved. Chalcones represent precursor compounds for flavonoids biosynthesis in plants. Chalcones, 1,3-diaryl-2-propen1-ones, have unique chemical structure with conjugated double bonds and delocalized π-electron system on both aromatic rings. Various studies have shown that chemical structure of chalcone is responsible for their antitumor effect. In our study, we have examined the antitumor effect of chalcone analogue (E)-1-(4-ethoxy-3-methoxyphenyl)-5methylhex-1-en-3-one (CH) on HeLa cells. The antitumor efficiency of different CH concentrations was compared to the antitumor effects of dehydrozingerone and cisplatin. The viability of the cells was evaluated using MTT assay; type of the cell death was evaluated by Annexin V-FITC/7-AAD staining using FACS analysis; morphology changes of treated cells were visualized and compared to untreated cells using phase contrast microscopy. The result of our research showed that CH have a stronger antitumor compared to the effect both of dehydrozingerone and cisplatin. Our results indicated that chalcone analogue induced cell death via activation of apoptosis more powerfully compared to the apoptosis induced with dehydrozingerone and cisplatin.
URI: https://scidar.kg.ac.rs/handle/123456789/8298
Type: Article
DOI: 10.2478/SJeCR-2018-0048
ISSN: 18208665
SCOPUS: 85078841866
Appears in Collections:Faculty of Medical Sciences, Kragujevac
[ Google Scholar ]

Page views(s)

18

Downloads(s)

1

Files in This Item:
File Description SizeFormat 
10.2478-SJeCR-2018-0048.pdf402.83 kBAdobe PDFThumbnail
View/Open


Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.